These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9749370)

  • 1. Molecular modeling of the human vasopressin V2 receptor/agonist complex.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    J Comput Aided Mol Des; 1998 May; 12(3):275-87. PubMed ID: 9749370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling of the vasopressin V2 receptor/antagonist interactions.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    Acta Biochim Pol; 1998; 45(1):19-26. PubMed ID: 9701492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
    Giełdoń A; Kaźmierkiewicz R; Slusarz R; Ciarkowski J
    J Comput Aided Mol Des; 2001 Dec; 15(12):1085-104. PubMed ID: 12160092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors.
    Slusarz MJ; Sikorska E; Slusarz R; Ciarkowski J
    J Med Chem; 2006 Apr; 49(8):2463-9. PubMed ID: 16610789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics of a vasopressin V2 receptor in a phospholipid bilayer membrane.
    Czaplewski C; Pasenkiewicz-Gierula M; Ciarkowski J
    J Recept Signal Transduct Res; 1999; 19(1-4):355-67. PubMed ID: 10071770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of the oxytocin receptor/bioligand interactions.
    Politowska E; Czaplewski C; Ciarkowski J
    Acta Biochim Pol; 1999; 46(3):581-90. PubMed ID: 10698266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pharmacology and modeling of vasopressin receptors.
    Thibonnier M; Coles P; Thibonnier A; Shoham M
    Prog Brain Res; 2002; 139():179-96. PubMed ID: 12436935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for V2 vasopressin receptor proteolytic cleavage.
    Kojro E; Postina R; Gilbert S; Bender F; Krause G; Fahrenholz F
    Eur J Biochem; 1999 Dec; 266(2):538-48. PubMed ID: 10561596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.
    Mouillac B; Chini B; Balestre MN; Elands J; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Jard S; Barberis C
    J Biol Chem; 1995 Oct; 270(43):25771-7. PubMed ID: 7592759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for K268 in V2R folding.
    Gouill CL; Darden T; Madziva MT; Birnbaumer M
    FEBS Lett; 2005 Sep; 579(22):4985-90. PubMed ID: 16115624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics and structural communication in the ternary complex of fully phosphorylated V2 vasopressin receptor, vasopressin, and β-arrestin 1.
    Bellucci L; Felline A; Fanelli F
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183355. PubMed ID: 32413442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism.
    de la Nuez Veulens A; Ginarte YMÁ; Fernandez RER; Leclerc F; Cabrera LAM
    J Mol Model; 2022 Jan; 28(2):31. PubMed ID: 34997307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal juxtamembrane segment of the V1a vasopressin receptor provides two independent epitopes required for high-affinity agonist binding and signaling.
    Hawtin SR; Wesley VJ; Simms J; Argent CC; Latif K; Wheatley M
    Mol Endocrinol; 2005 Nov; 19(11):2871-81. PubMed ID: 15994199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I8-arachnotocin-an arthropod-derived G protein-biased ligand of the human vasopressin V
    Duerrauer L; Muratspahić E; Gattringer J; Keov P; Mendel HC; Pfleger KDG; Muttenthaler M; Gruber CW
    Sci Rep; 2019 Dec; 9(1):19295. PubMed ID: 31848378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
    Chini B; Mouillac B; Ala Y; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M; Jard S
    EMBO J; 1995 May; 14(10):2176-82. PubMed ID: 7774575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.
    Conner M; Hawtin SR; Simms J; Wootten D; Lawson Z; Conner AC; Parslow RA; Wheatley M
    J Biol Chem; 2007 Jun; 282(24):17405-12. PubMed ID: 17403667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.